Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2014 (2014), Article ID 157625, 4 pages
http://dx.doi.org/10.1155/2014/157625
Clinical Study

Effects of a New Patient Safety-Driven Oxytocin Dosing Protocol on Postpartum Hemorrhage

Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Miami Valley Hospital, Dayton, OH 45409, USA

Received 11 November 2013; Accepted 4 April 2014; Published 27 April 2014

Academic Editor: Jeffrey Keelan

Copyright © 2014 David S. McKenna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Institute of Medicine (US), To Err Is Human: Building a Safer Health System, National Academy Press, Washington, DC, USA, 2000.
  2. American College of Obstetricians and Gynecologists, “ACOG Committee opinion number 447: patient safety in obstetrics and gynecology,” Obstetrics and Gynecology, vol. 114, no. 6, pp. 1424–1427, 2009. View at Google Scholar
  3. Science of Improvement: Establishing Measures 2014, Institute for Healthcare Improvement, http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementEstablishingMeasures.aspx.
  4. Oxytocin Order Set 2007, Hospital Corporation of America, http://www.idahoperinatal.org/documents/OxytocinOrderSetAug2007.pdf.
  5. S. Clark, M. Belfort, G. Saade et al., “Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes,” American Journal of Obstetrics and Gynecology, vol. 197, no. 5, pp. 480.e1–480.e6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Clark, K. R. Simpson, G. E. Knox, and T. J. Garite, “Oxytocin: new perspectives on an old drug,” American Journal of Obstetrics and Gynecology, vol. 200, no. 1, pp. 35.e1–35.e6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. Hayes and L. Weinstein, “Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin,” American Journal of Obstetrics and Gynecology, vol. 198, no. 6, pp. 622.e1–622.e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Jonsson, S. L. Nordén, and U. Hanson, “Analysis of malpractice claims with a focus on oxytocin use in labour,” Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 3, pp. 315–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. American College of Obstetricians and Gynecologists, “Practice bulletin number 76. Post partum hemorrhage,” Obstetrics and Gynecology, vol. 108, pp. 1039–1047, 2006. View at Google Scholar
  10. F. Silverman and E. Bornstein, Uterotonic Agents for the Management of the Third Stage of Labor, C. J. Lockwood, V. A. Barss, Ed., Uptodate, Waltham, Mass, USA, 2013.
  11. G. Westhoff, A. M. Cotter, and J. E. Tolosa, “Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage (Review),” in The Cochrane Library. Issue 10, Wiley, Chichester, UK, 2013. View at Google Scholar
  12. A. T. N. Tita, J. M. Szychowski, D. J. Rouse et al., “Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial,” Obstetrics and Gynecology, vol. 119, no. 2, pp. 293–300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. S. McKenna, S. W. Costa, and P. Samuels, “Prostaglandin E2 cervical ripening without subsequent induction of labor,” Obstetrics and Gynecology, vol. 94, no. 1, pp. 11–14, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. D. S. McKenna, J. B. Ester, M. Proffitt, and K. R. Waddell, “Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial,” Obstetrics and Gynecology, vol. 104, no. 3, pp. 579–584, 2004. View at Publisher · View at Google Scholar · View at Scopus